<DOC>
	<DOCNO>NCT01082302</DOCNO>
	<brief_summary>This open , monocentric study design investigate plasma concentration certain catechin topical application Veregen 15 % ointment genital perianal wart comparison catechin plasma concentration oral intake define dose green tea beverage . The study intend demonstrate topical administration Veregen 15 % induces catechin plasma concentration lower equivalent reach normal consumption green tea .</brief_summary>
	<brief_title>Pharmacokinetic Study Topically Applied Veregen 15 % Compared With Oral Intake Green Tea Beverage</brief_title>
	<detailed_description />
	<mesh_term>Warts</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<criteria>For subject group ( treatment arm 1 + 2 ) : 1 . Male female subject , 18 year age old time enrollment . Subjects stratify gender . 2 . Written informed consent . 3 . Ability comply requirement study . For patient ( treatment arm 1 , additionally ) : 4 . Clinical diagnosis external genital perianal wart locate : men : glans penis , foreskin , penis shaft , scrotum ; woman : vulva ; gender : inguinal , perineal , perianal area . 5 . A total wart area least 100 mm² maximum 2500 mm² . 6 . For woman childbearing potential : negative pregnancy test willingness use two effective method contraception throughout study participation mandatory ( oral contraceptive , hormone contain intrauterine device , depot injection , hormone implant , sterilization ( contraception ) plus condom ( prevention reinfection ) . For male patient partner male patient childbearing potential : use two method effective contraception treatment period mandatory ( oral contraceptive , hormone contain intrauterine device , depot injection , hormone implant , sterilization ( contraception ) plus condom ( prevention reinfection ) . For subject group ( treatment arm 1 + 2 ) : 1 . Participation investigational trial within 30 day prior enrollment whole study duration . 2 . Any current uncontrolled infection . 3 . Current know acute chronic infection Hepatitis virus B C. 4 . Known Human immunodeficiency virus infection . 5 . Subjects know history chronic ( diabetes , hypertension , gastritis , etc . ) consume disease ( cancer , multiple sclerosis , etc . ) , chronic inflammation , liver renal insufficiency . 6 . Any chronic acute condition include skin , susceptible , opinion investigator , interfere evaluation drug effect . 7 . Laboratory data upper normal range . 8 . Systemic intake virostatics within 30 day prior enrollment whole study duration , exception acyclovir related drug famciclovir valaciclovir . 9 . Systemic intake immunosuppressive immunomodulatory medication vaccination within 30 day prior enrollment whole study duration . 10 . Organ allograft recipient . 11 . Medication intake , include counter product dietary supplement iodine , fluoride , vitamin , would interfere study result , except paracetamol oral contraceptive , within one week study course . Subjects allow consume green , black Oolong tea well red wine beverage food contain green tea extract within three day blood sample visit . 12 . For female patient : pregnancy lactation . 13 . Blood transfusion within 30 day prior enrollment . 14 . Subjects place institution due judicial official directive . For patient ( treatment arm 1 , additionally ) : 15 . Previous participation trial investigate sinecatechins treatment external genital perianal wart . 16 . Treatment external genital wart within 30 day prior enrollment whole study duration . 17 . Current infection Herpes genitalis history Herpes genitalis infection within last 3 month prior enrollment . 18 . Any current and/or recurrent pathologically relevant genital infection genital wart . 19 . Known allergy ingredient ointment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>green tea extract</keyword>
	<keyword>Polyphenon E</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>